ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 54 | +14.9% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 47 | -37.3% | 0.00% | – |
Q4 2018 | $3,000 | -50.0% | 75 | -24.2% | 0.00% | – |
Q3 2018 | $6,000 | +20.0% | 99 | +20.7% | 0.00% | – |
Q2 2018 | $5,000 | -37.5% | 82 | -34.4% | 0.00% | – |
Q1 2018 | $8,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | 0.0% | 125 | -17.2% | 0.00% | – |
Q3 2017 | $8,000 | +14.3% | 151 | 0.0% | 0.00% | – |
Q2 2017 | $7,000 | 0.0% | 151 | +11.9% | 0.00% | – |
Q1 2017 | $7,000 | 0.0% | 135 | +15.4% | 0.00% | – |
Q4 2016 | $7,000 | -12.5% | 117 | 0.0% | 0.00% | – |
Q3 2016 | $8,000 | +700.0% | 117 | +588.2% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 17 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |